Full-Time

Associate Director GMP Quality Operations

Posted on 2/21/2025

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$139.1k - $173.9kAnnually

+ Discretionary Bonus + Equity Awards

Senior, Expert

San Diego, CA, USA

This position requires in-office work three days per week on average.

Category
Diagnostics & Laboratory Professionals
Healthcare Administration & Support
Medical, Clinical & Veterinary

You match the following Acadia Pharmaceuticals's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in Chemistry/Biology or related life science
  • Targeting 8 years related and progressively responsible experience within the pharmaceutical or biopharmaceutical industry with a minimum of 4 years in a leadership role
  • Five years in Quality Assurance strongly preferred
  • Demonstrated knowledge of Quality Assurance activities and International Conference on Harmonization (ICH) and FDA/EU GMP regulations as they relate to clinical trials, product development, commercial requirements and technology transfer
  • Strong problem-solving skills
  • Ability to lead a cross-functional team to develop solutions to a complex problem or advance a continuous improvement or preventive action opportunity
  • Experience implementing and managing quality management systems
  • Demonstrated proficiency in interpretations of cGMP regulations, both US and international
  • Skilled at effectively communicating department or area issues and results within and across functional areas and conducting presentations of technical information concerning specific projects or timelines
  • Able to gain cooperation of others
  • Experience conducting internal and supplier audits and manufacturing facility inspections
  • Ability to interpret and relate Quality standards for implementation and review
  • Strong focus on flexibility, ability to multi-task, attention to detail, excellent organizational skills, good follow-up and judgment and ability to prioritize
  • Skilled at effectively leading a cooperative team effort and organizing resources to achieve team goals
  • Able to make and prioritize process and resource decisions based on overall team needs
  • Ability to travel up to 20%
Responsibilities
  • Manages the batch disposition process for all Acadia drug product and substance production
  • May serve as a key point of contact with CMO partners and ensures integrated, coordinated activities related to cGMP production and continuous improvement
  • Leads or participates in formal risk assessment activities
  • Provides on-site quality support at CMOs as required
  • Participates in the design, implementation and management of the Acadia GMP quality management system, based on FDA and applicable international regulations
  • Ensures compliance of the Acadia GMP quality management system with FDA and applicable international quality management system regulations
  • Participates in GMP supplier audits and Acadia documentation control systems
  • Participates in the review of, and ensures conformance to, Quality Agreements with GMP contract service providers for outsourced operations
  • Provides guidance to SMEs and acts as QA lead on investigations, change management and batch record review, and establishing effective CAPA plans
  • Participates in and/or leads QA in continuous improvement of Acadia quality management systems according to GMP and current industry standards
  • Ensures adequate QA representation on all GMP commercial manufacturing, supply chain, and product development teams
  • Recommends changes to policies and establishes procedures that affect the functional area and may also have company-wide effect
  • Participates in Quality Operations functions, such as: Material Review Board, quality board, strategic planning efforts, etc., as required by Acadia Management
  • Develops and/or contributes metrics to support product and/or process review efforts as needed
  • Other duties as assigned/required
Desired Qualifications
  • Professional certifications from American Society for Quality (ASQ), or equivalent, are a strong plus
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, which are then approved by regulatory bodies like the FDA before being sold to patients and healthcare providers. What sets Acadia apart from competitors is its long-standing commitment to addressing unmet medical needs in neuroscience, along with its emphasis on corporate social responsibility, including diversity and inclusion. The goal of Acadia Pharmaceuticals is to improve the quality of life for individuals suffering from challenging neurological diseases through effective treatments.

Company Size

501-1,000

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's recent Health Canada approval for Daybue boosts its market presence in Canada.
  • The exclusive license agreement with Saniona expands Acadia's drug portfolio with SAN711.
  • Hiring Thomas Andrew Garner as CCO strengthens Acadia's commercial leadership team.

What critics are saying

  • Increased competition in CNS drugs may impact Acadia's market share and growth.
  • Regulatory challenges could delay or prevent new drug approvals, affecting revenue.
  • High drug development costs may strain financial resources if trials are unsuccessful.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on unmet needs in neurological disorders like Parkinson's and Rett syndrome.
  • The company has a strong R&D pipeline with four product candidates in development.
  • Acadia collaborates with partners like Biovail to enhance drug development and commercialization.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Company News

Fierce Pharma
Dec 9th, 2024
Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead

Acadia Pharmaceuticals has hired Big Pharma veteran Thomas Andrew Garner as its new chief commercial officer (CCO).

MarketWatch
Nov 26th, 2024
Acadia Pharmaceuticals in Exclusive License Agreement With Saniona for SAN711

Acadia Pharmaceuticals on Tuesday said it entered into an exclusive worldwide license agreement with Saniona to develop and commercialize SAN711.

World Pharmaceuticals
Oct 17th, 2024
Acadia gets Health Canada approval for Daybue to treat Rett Syndrome

US-based biopharmaceutical company Acadia Pharmaceuticals has received Health Canada marketing authorisation for Daybue (trofinetide) to treat a rare genetic neurological disorder.

PRWeb
Aug 23rd, 2024
Global Genes' Annual Week In Rare Event Heading To Kansas City

"Week in RARE provides advocates a unique opportunity to participate in multiple events in one place to maximize their time, travel, and potential to gain benefits from their participation."

Yahoo Finance
Aug 15th, 2024
Ryan Reynolds Announces More To Parkinson'S(R) Campaign

Ryan & Tammy Reynolds (Photo: Business Wire)Acadia Parkinson's Fact Sheet-- The national disease awareness campaign aims to educate and drive conversation about recognizing and managing non-motor symptoms of Parkinson’s, including hallucinations and delusions-- Reynolds and his mother Tammy share their personal story about the impact of these symptoms on their familySAN DIEGO, August 14, 2024--(BUSINESS WIRE)--Ryan Reynolds, a world-renowned actor/entrepreneur and Parkinson’s disease advocate, with Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the launch of a multi-faceted disease education campaign, More to Parkinson’s®, to raise awareness among caregivers, patients and their care providers about a common, yet under-recognized aspect of Parkinson’s disease – Parkinson’s-related hallucinations and delusions.Notably, around half of the people living with Parkinson’s disease may develop hallucinations or delusions over the course of their disease, but up to 90% of people currently do not proactively tell their physicians about these symptoms.1-3 By sharing their experiences caring for Ryan’s father, James "Jim" Reynolds, who passed away nearly a decade ago, Ryan and his mother Tammy, aim to raise awareness, educate and drive conversation between people with Parkinson’s disease, their families and their doctors about how best to talk about and treat these non-motor symptoms."My father experienced hallucinations and delusions. At the time, we didn’t know any of these types of symptoms were part of his Parkinson’s disease," Reynolds explains. "Like a lot of caregivers, my mom mostly tried to carry these burdens alone. I wish I’d known Parkinson’s disease wasn’t limited to only motor symptoms. I think people and families affected by Parkinson’s can be better prepared to manage hallucinations and delusions if they’re talking early and often about this lesser-known aspect of the disease."This press release features multimedia